Back to profileComponent study · 2008

KPV in experimental colitis

PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation

Dalmasso G et al. · Gastroenterology

Study record

Population
Formulation
Route
Dose & frequency
Study design
Duration
Reported findings
Adverse events

What it supports

Mechanistic and preclinical evidence about KPV.

What it does not establish

Not a human clinical trial. Does not establish efficacy, dosing, or safety of KLOW.

Funding

Not extracted in this pilot

Checked 2026-09-08 · Abstract-level extraction · Clinical/editorial review pending

Open original publication

Source detail

Source record unavailable. Close this panel and select another field.